Skip to main content

Advertisement

Table 4 Adverse events recorded during the study among participants

From: Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers

Adverse events Total Atomoxetine (n = 9) Placebo (n = 8)
Insomnia 7 5 (55.6%) 2 (25.0%)
Anxiety/nervousness 2 3 (33.3%) 0 (0%)
Dry mouth 3 3 (33.3%) 0 (0%)
Dizziness 5 2 (22.2%) 3 (37.5%)
Fatigue 4 2 (22.2%) 2 (25.0%)
Nausea 4 2 (22.2%) 2 (25.0%)
Decreased concentration 4 2 (22.2%) 2 (25.0%)
Headache 4 2 (22.2%) 2 (25.0%)
Diaphoresis 3 2 (22.2%) 1 (12.5%)
Urinary retention 2 2 (22.2%) 0 (0%)
Increased energy, feeling 'high' 2 2 (22.2%) 0 (0%)
Paresthesia (tingling sensation) 2 2 (22.2%) 0 (0%)
Restless 2 2 (22.2%) 0 (0%)
Irritability 2 2 (22.2%) 0 (0%)
Sadness/low mood 2 1 (11.1%) 1 (12.5%)
Common cold 2 1 (11.1%) 1 (12.5%)
Diarrhea 1 1 (11.1%) 0 (0%)
Constipation 1 1 (11.1%) 0 (0%)
Sexual dysfunction 1 1 (11.1%) 0 (0%)
Chills 1 1 (11.1%) 0 (0%)
Tense 1 1 (11.1%) 0 (0%)
Feeling that time goes fast/speedy 1 1 (11.1%) 0 (0%)
Decreased appetite 1 1 (11.1%) 0 (0%)
Recklessness 1 1 (11.1%) 0 (0%)
Stomach pain 1 1 (11.1%) 0 (0%)
Fall 2 0 (0%) 2 (25.0%)
Sinusitis 1 0 (0%) 1 (12.5%)
Bladder infection 1 0 (0%) 1 (12.5%)
Heart palpitation 1 0 (0%) 1 (12.5%)
Other (assault, car accident) 4 2 (22.2%) 0 (0%)